Significance of Monoclonal Antibodies against the Conserved Epitopes within Non-Structural Protein 3 Helicase of Hepatitis C Virus

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Bian, Yixin ^a   Zhao, Shuoxian ^a   Zhu, Shaomei ^a   Zeng, Jinfeng ^b   Li, Tingting ^a   Fu, Yongshui ^c   Wang, Yuanzhan ^a   Zheng, Xin ^b   Zhang, Ling ^a   Wang, Wenjing ^a   Yang, Baocheng ^b   Zhou, Yuanping ^a   Allain, Jean Pierre ^a,d   Li, Chengyao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b E mail: szbloodcenter hotmailcom   (China)

^c Guangzhou Blood Center   (China)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2E12; MONOCLONAL ANTIBODY 3E5; NONSTRUCTURAL PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY COMBINING SITE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME CONFORMATION; EPITOPE MAPPING; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 84880789402     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070214     Document Type: Article

References (28)

1. Kim WR, (2002) Global epidemiology and burden of hepatitis C. Microbes. Infect4: 1219-1225.
2. Suzich JA, Tamura JK, Palmer-Hill F, Warrener P, Grakoui A, et al. (1993) Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with related pestivirus and flavirus enzymes. J Virol 67: 6152-6158.
3. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, et al. (1991) Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337: 317-319.
4. Mondelli M, Cerino A, Boender P, Oudshoorn P, Middeldorp J, et al. (1994) Significance of the immune response to a major conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol 68: 4829-4836.
5. Zhang ZX, Lazdina U, Chen M, Peterson DL, Sällberg M, (2000) Characterization of a monoclonal antibody and its single-chain antibody fragment recognizing the nucleoside Triphosphatase/Helicase domain of the hepatitis C virus nonstructural 3 protein. Clin Diagn Lab Immunol 7: 58-63.
6. Jolivet-Reynaud C, Adida A, Michel S, Deléage G, Paranhos-Baccala G, et al. (2004) Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase. J Med Virol 72: 385-395.
7. Chen M, Sällberg M, Sönnerborg A, Jin L, Birkett A, et al. (1998) Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein. Hepatology 28: 219-224.
8. Rice CM, (2011) New insights into HCV replication: potential antiviral targets. Top Antivir Med 19: 117-120.
9. Walker JE, Saraste M, Runswick MJ, Gay NJ, (1982) Distantly related sequences in the a- and f-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. The EMBO Journal l: 945-951.
10. Lam AM, Keeney D, Frick DN, (2003) Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action. J Biol Chem 278: 44514-44524.
11. Frick DN, (2007) The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Curr Issues Mol Biol 9: 1-20.
12. Raney KD, Sharma SD, Moustafa IM, Cameron CE, (2010) Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J Biol Chem 285: 22725-22731.
13. Lin C, Kim JL, (1999) Structure-based mutagenesis study of hepatitis C virus NS3 helicase. J Virol 73: 8798-807.
14. Dillingham MS, Soultanas P, Wiley P, Webb MR, Wigley DB, (2001) Defining the roles of individual residues in the single-stranded DNA binding site of PcrA helicase. Proc Natl Acad Sci U S A 98: 8381-8387.
15. Zhang L, Yin S, Tan W, Xiao D, Weng Y, et al. (2012) Recombinant interferon-γ lentivirus co-infection inhibits adenovirus replication ex vivo. PLoS ONE 7: e42455.
16. Li C, Candotti D, Allain JP, (2001) Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1. J Virol 75: 12412-12420.
17. Li T, Chen Z, Zeng J, Zhang J, Wang W, et al. (2011) Impact of host responses on control of hepatitis C virus infection in Chinese blood donors. Biochem Biophys Res Commun 415: 503-508.
18. Tani H, Fujita O, Furuta A, Matsuda Y, Miyata R, et al. (2010) Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro. Biochem Biophys Res Commun 393: 131-136.
19. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, et al. (1992) Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 16: 306-311.
20. Wilkinson J, Radkowski M, Laskus T, (2009) Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 83: 1312-1319.
21. Cao Y, Zhang Y, Wang S, Zou W, (2009) Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis. Nephrol Dial Transplant 24: 2745-2751.
22. Giugliano S, Oezkan F, Bedrejowski M, Kudla M, Reiser M, et al. (2009) Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3. Hepatology50: 707-16.
23. Bukh J, Apgar CL, Yanagi M, (1999) Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent. Virology 262: 470-478.
24. Khudyakov Y, Khudyakova NS, Jue DL, Lambert SB, Fang S, et al. (1995) Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology 206: 666-672.
25. Sullivan DE, Mondelli MU, Curiel DT, Krasnykh V, Mikheeva G, et al. (2002) Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein. J Hepatol 37: 660-668.
26. Prabhu R, Khalap N, Burioni R, Clementi M, Garry RF, et al. (2004) Inhibition of hepatitis C virus nonstructural protein, helicase activity, and viral replication by a recombinant human antibody clone. Am J Pathol 165: 1163-1173.
27. Chandra PK, Hazari S, Poat B, Gunduz F, Prabhu R, et al. (2010) Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone. Virol J 7: 118.
28. Chang SC, Cheng JC, Kou YH, Kao CH, Chiu CH, et al. (2000) Roles of the AX(4)GKS and arginine-rich motifs of hepatitis C virus RNA helicase in ATP- and viral RNA-binding activity. J Virol 4: 9732-9737.